Press release content from PR Newswire. The AP news staff was not involved in its creation.
WeLab completes initial close of Series C-1 funding, led by Allianz X for US$75 million and announces strategic partnership
March 8, 2021 GMT
WeLab completes initial close of Series C-1 funding, led by Allianz X for US$75 million and announces strategic partnership
WeLab completes initial close of Series C-1 funding, led by Allianz X for US$75 million and announces strategic partnership
WeLab’s focus on technology and innovation in building a pan-Asian digital financial services platform complements Allianz’s expansion strategy with technology-focused partners in the region
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for .
Cara Therapeutics, Inc.March 8, 2021 GMT
FDA has set Prescription Drug User Fee Act (PDUFA) target action date of August 23, 2021
If approved, KORSUVA™ injection would be first therapy for treatment of pruritus in hemodialysis patients
STAMFORD, Conn, and ST. GALLEN, Switzerland, March 08, 2021 (GLOBE NEWSWIRE) Cara Therapeutics (Nasdaq:CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the New Drug Application (NDA) for KORSUVA™ (difelikefalin) solution for injection for the treatment of moderate-to-severe pruritus in hemodialysis patients. The PDUFA target action date for KORSUVA is August 23, 2021. The FDA stated that currently it is not planning to hold an advisory committee meeting to discuss the
Press release content from Business Wire. The AP news staff was not involved in its creation.
New Patent Puts NotCo in the Front Seat of Technology Breakthrough in the Food Industry
March 8, 2021 GMT
New Patent Puts NotCo in the Front Seat of Technology Breakthrough in the Food Industry (Photo: Business Wire)
New Patent Puts NotCo in the Front Seat of Technology Breakthrough in the Food Industry (Photo: Business Wire)
NEW YORK (BUSINESS WIRE) Mar 8, 2021
Just after a few months of launching its NotMilk TM at Whole Foods Market nation-wide in the U.S., the leading food-tech in Latin America, backed by key venture capital names, including Jeff Bezos, announces it has been granted a patent for its proprietary artificial intelligence technology in the U.S.
Press release content from Accesswire. The AP news staff was not involved in its creation.
Namibia Critical Metals Inc. Increases Private Placement to $662,500
March 8, 2021 GMT
HALIFAX, NOVA SCOTIA / ACCESSWIRE / March 8, 2021 / Namibia Critical Metals Inc. (“Namibia Critical Metals” or the “Company” or “NMI”) (TSXV:NMI) announced that, as a result of investor interest, the Company is increasing the non-brokered private placement previously announced on March 3, 2021 from a maximum of Cdn$500,000 to a maximum of Cdn$662,500. The private placement is for units with each unit consisting of one common share and one warrant. Each whole warrant will be exercisable for one common share at a price of $0.35 for a period of 12 months. A maximum of 5,300,000 common shares of Namibia Critical Metals will be issued pursuant to the Private Placement (assuming full exercise of all warrants). The Private Placement is subject to the approval of the TSX Venture Exchange (“TSXV”).